Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to start review
Explore by Goal
"The day science begins to study non-physical phenomena, it will make more progress in one decade than in all the previous centuries of its existence."
- Nikola Tesla
Quick Explanation
Copied
Muscle-specific ageing gene-expression signature
In a zebrafish GH-excess (acromegaly) model, the paper reports that GenAge ageing gene sets are significantly enriched in muscle (GSEA; p<0.01, FDR q=0.08 by the paper), with substantial overlap between acromegaly and aged-DEGs across muscle/liver/brain; overlapping genes are enriched for metabolism, hypoxia response, and ER stress (notably in liver).
Confidence caveat: these are transcriptomic signature/enrichment results (inference about ageing) rather than direct causal ageing phenotyping in each tissue.
Key analyses: GenAge GSEA, hierarchical clustering, DEG overlaps (Venn), GO/KEGG/Reactome/BioPlanet enrichment; RNA-seq data used from GEO: GSE113169 and GSE153755.
All claims above are from the provided manuscript text and its stated methods/results
What the paper does (as stated): Tests whether zebrafish GH-excess (acromegaly model) shows an ageing-related gene-expression signature in multiple organs using GenAge gene sets, DEG overlaps with aged zebrafish, and pathway/GO enrichment; it also reports a cross-species check using GH-cultured human oocytes.
1) Visual map of the evidence chain
Nodes/links reflect the paper’s stated workflow: RNA-seq inputs from GEO; orthologue mapping; GSEA; clustering; DEG overlap; enrichment; plus a human oocyte GH exposure check.
2) Main reported results (organ specificity)
2.1 GenAge GSEA: significant in muscle
The manuscript reports positive ageing-score enrichment in all tested acromegaly organs, but significance (GSEA p<0.01; FDR q=0.08 stated) only in acromegaly muscle.
This plot intentionally does not encode the magnitude of enrichment scores because those values are not provided in the supplied text; it only reflects the stated significance outcome.
The manuscript reports that overlapping DEGs between acromegaly and aged zebrafish show directional concordance: acromegaly-up DEGs overlap with aged-up DEGs (not down), and vice versa.
It also gives several overlap fractions: muscle (more than 50% of acromegaly-down DEGs overlap aged-down; about 40% of up overlap aged-up), and reports additional ~40% overlap for liver and ~65%/40% for brain down/up respectively (as written).
Liver separation into up/down overlap fractions is not explicitly provided in the supplied text, so the visualization only uses the narrative’s stated ~40% overlap (without splitting directions).
3) Biological themes of overlap (muscle vs liver vs brain)
3.1 Muscle overlap: ageing metabolism
GO and pathway enrichment of overlapping muscle DEGs is described as highlighting metabolic pathways/categories (including ethanol/oxoacid/steroid metabolism), with most enriched pathways related to metabolism; the manuscript additionally quantifies that roughly ~50% of down-overlapping DEGs and ~20% of up-overlapping DEGs are metabolism-related.
3.2 Liver overlap: hypoxia + ER stress + metabolism
For liver overlapping DEGs, GO themes are described as metabolic pathways, response to hypoxia, and ER stress, including PERK-mediated unfolded protein response and related terms; the manuscript also states GSEA shows significant downregulation of response to hypoxia in liver for both acromegaly and aged zebrafish.
This graph avoids implying numeric shares because the supplied excerpt does not provide exact per-category percentages.
The manuscript describes brain overlapping DEGs enriched for transcriptional regulation, DNA binding, neurotrophin binding, and neurotransmitter transport regulation (plus synapse/cell projection-related cellular components). It also lists pathway enrichments (e.g., gap junction, circadian entrainment, long-term potentiation, MAPK signalling).
4) Cross-species check: GH-cultured human oocytes
The paper reports that GH-cultured human oocytes show significant upregulation of ageing-related gene sets by GSEA, including a dataset associated with premature ageing disorder (Werner syndrome; MSigDB M1996) and another ageing dataset (MSigDB M2144), with significance thresholds described in the text.
Note on limits
The supplied excerpt does not include the oocyte dataset’s exact experimental design (e.g., dosing, duration, replicates), so mechanistic inference remains constrained.
Multi-pronged “ageing signature” logic: the manuscript doesn’t rely on a single plot; it uses GenAge GSEA, clustering similarity, and DEG overlap directionality (up↔up; down↔down) before pathway enrichment.
Explicit ageing gene-set resources: the analysis uses GenAge plus additional ageing gene sets (e.g., MSigDB Werner syndrome and another ageing signature) and reports orthologue conversion via Biomart.
Key limitations / blind spots (what could mislead)
Transcriptomics ≠ ageing causality: “ageing genetic signature” claims are inferential (gene-expression enrichment) and do not establish that GH excess causally produces ageing at functional/physiological levels in each tissue.
Sample sizes and uncertainty details are incomplete in the supplied text: the narrative indicates biological replicates but does not specify exact n for each organ/condition in the excerpt you provided.
Cross-species orthologue mapping risk: mapping zebrafish genes to human orthologues and using human-centric ageing gene sets can introduce annotation/orthology biases that affect enrichment results.
Multiple-testing/enrichment interpretation: thresholds are stated for significance (p<0.05; and FDR q-values in the narrative), but without the full statistical output in the excerpt, it’s hard to assess robustness across gene-set sizes and correlations (a known general concern for GSEA-based inference).
Possible “directionality” confirmation bias: the strong claim that overlaps occur in the same direction (up with up; down with down) is compelling, but without listing the DEGs and effect directions plus validation, it’s difficult to rule out how gene-set definition and DEG calling thresholds shape the concordance.
6) Reproducibility & how to verify using the paper’s stated inputs
The paper indicates RNA-seq is available in GEO (GSE113169, GSE153755) and outlines the analysis steps: DEG calling (cummerbund; adj p<0.05), hierarchical clustering (heatmap.2), GSEA (GenAge and additional gene sets) after orthologue mapping (Biomart), and pathway enrichment (ENRICHR/GO/Reactome/KEGG/BioPlanet).
Component
What the paper states
Why it matters
RNA-seq datasets
GSE113169, GSE153755 (acromegaly/WT/aged across organs)
Allows exact raw re-analysis if consistent processing is available.
Ageing gene sets
GenAge (plus MSigDB ageing and Werner syndrome datasets for oocyte analysis)
Gene-set content defines what “ageing signature” means.
Orthologue mapping
Biomart conversion to human orthologues before GSEA
Can affect gene membership in human-centric gene sets.
Downstream enrichment
ENRICHR, GO, Reactome, KEGG, BioPlanet
Multiple databases can agree/disagree depending on annotations.
Author review links
Feedback:
Updated: April 18, 2026
BGPT Paper Review
Study Novelty
80%
The novelty is largely methodological/analytic: combining a GH-excess zebrafish acromegaly model with cross-organ ageing gene-set enrichment (GenAge), organ-specific DEG overlap directionality, and a cross-species human GH-oocyte GSEA check to argue for an “ageing genetic signature” tied to hypersomatotropism. This extends prior work in the same model but remains within established transcriptomic signature paradigms.
Scientific Quality
70%
Moderately strong: the paper uses multiple complementary transcriptomic analyses (GSEA, clustering, DEG overlap with directionality, and multi-database pathway enrichment) and points to accessible GEO datasets. Key red flags from the provided excerpt: sample-size details are not fully visible, effect-size/robustness metrics (beyond stated thresholds) are not inspectable here, orthologue mapping introduces bias risk, and the ageing interpretation is proxy-based rather than directly functionally validated in each tissue.
Study Generality
60%
Findings are biologically suggestive but constrained: strong muscle-specific signature is emphasized, and causal generalization to human acromegaly ageing across tissues is not directly demonstrated (human component is a cell-exposure transcriptomic signature). Still, the mechanistic themes (metabolism, hypoxia response, ER stress) are broadly relevant aging-associated processes.
Study Usefulness
70%
Useful for hypothesis generation and target prioritization: it provides a tissue-patterned map of ageing-associated transcriptional themes under GH excess and points to specific pathway classes (metabolism, hypoxia, ER stress). However, it is not a definitive mechanistic causal study and lacks direct functional ageing endpoints in the excerpt provided.
Study Reproducibility
60%
Reproducibility is moderate: GEO accession numbers are provided and the analysis pipeline is described at a high level. But full statistical parameters, DEG lists, and exact sample sizes/replicate counts per comparison are not fully extractable from the provided text, reducing re-check ability from this excerpt alone.
Explanatory Depth
60%
The paper offers pathway-level explanations (metabolism/hypoxia/ER stress) that are coherent with ageing literature, but it remains largely correlational at the transcriptomic signature level. Mechanistic links from GH/IGF-1 to each enriched process are not established experimentally within this paper’s excerpt.
Downloads GEO RNA-seq for WT/acromegaly/aged, runs orthologue mapping and computes gene set enrichment against GenAge across organs, then outputs overlap/up-down concordance summaries for replication.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The “ageing signature” is not causally driven by GH excess but is instead a general response to stress/changes in metabolic state common to many chronic perturbations; this would weaken the hypersomatotropism-specific interpretation.
The muscle signal is an artifact of differential DEG calling thresholds or orthologue mapping coverage rather than a true biological tissue specificity; this would reduce confidence in organ-level conclusions.
Quick Explanation
Long Explanation
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Explore by Goal
Top Data Sources
Ask a Follow-Up
Key Insight
